The September issue of The Lancet Microbe is now online:
https://www.thelancet.com/journals/lanmic/issue/current
The journal is #OpenAccess 🔓, so you are free to explore all of its content, but these hashtags offer a flavour:
#SARSCoV2 #COVID19 #Streptococcus #pneumococcus #LoaLoa #loiasis #YellowFever #metapneumovirus #vaccine #PCV #LongCovid
#openaccess #SarsCoV2 #COVID19 #streptococcus #pneumococcus #loaloa #loiasis #yellowfever #metapneumovirus #vaccine #pcv #LongCovid #oa
We are pleased to join the #eWHORM project, a new multidisciplinary consortium of Sub-Saharan African & European research institutes, universities & non‑profits. @BNITM_de will conduct the clinical trials on #Loiasis in collaboration with @CERMEL_Gabon.
👉🏾http://bit.ly/3Ut2Myv
The February issue of The Lancet Microbe is now online:
https://www.thelancet.com/journals/lanmic/issue/current
The journal is #OpenAccess, so you are free to explore all of the content, but these hashtags offer a flavour:
#probiotic #Bacillus #Staphylococcus #Mycobacterium #tuberculosis #TB #WGS #DST #AMR #LoaLoa #loiasis #HIV
#oa #hiv #loiasis #loaloa #AMR #dst #wgs #tb #tuberculosis #mycobacterium #staphylococcus #Bacillus #probiotic #openaccess
New research article in The Lancet Microbe> Evaluating post-treatment #LoaLoa microfilarial densities to classify serious adverse events caused by #ivermectin: a retrospective analysis
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(22)00331-7/fulltext
#onchocerciasis #loiasis #ivermectin #loaloa